These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32210710)

  • 41. Interferon-α and cyclooxygenase-2 inhibitor cooperatively mediates TRAIL-induced apoptosis in hepatocellular carcinoma.
    Zuo C; Qiu X; Liu N; Yang D; Xia M; Liu J; Wang X; Zhu H; Xie H; Dan H; Li Q; Wu Q; Burns M; Liu C
    Exp Cell Res; 2015 May; 333(2):316-326. PubMed ID: 25724899
    [TBL] [Abstract][Full Text] [Related]  

  • 42. IFN-γ-secreting-mesenchymal stem cells exert an antitumor effect in vivo via the TRAIL pathway.
    Yang X; Du J; Xu X; Xu C; Song W
    J Immunol Res; 2014; 2014():318098. PubMed ID: 24971369
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Augmenting the antitumor effect of TRAIL by SOCS3 with double-regulated replicating oncolytic adenovirus in hepatocellular carcinoma.
    Wei RC; Cao X; Gui JH; Zhou XM; Zhong D; Yan QL; Huang WD; Qian QJ; Zhao FL; Liu XY
    Hum Gene Ther; 2011 Sep; 22(9):1109-19. PubMed ID: 21361790
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stronger growth-inhibitory effect of interferon (IFN)-beta compared to IFN-alpha is mediated by IFN signaling pathway in hepatocellular carcinoma cells.
    Damdinsuren B; Nagano H; Wada H; Kondo M; Ota H; Nakamura M; Noda T; Natsag J; Yamamoto H; Doki Y; Umeshita K; Dono K; Nakamori S; Sakon M; Monden M
    Int J Oncol; 2007 Jan; 30(1):201-8. PubMed ID: 17143530
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Partial contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway to antitumor effects of interferon-alpha/5-fluorouracil against Hepatocellular Carcinoma.
    Yamamoto T; Nagano H; Sakon M; Wada H; Eguchi H; Kondo M; Damdinsuren B; Ota H; Nakamura M; Wada H; Marubashi S; Miyamoto A; Dono K; Umeshita K; Nakamori S; Yagita H; Monden M
    Clin Cancer Res; 2004 Dec; 10(23):7884-95. PubMed ID: 15585621
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Parthenolide sensitizes hepatocellular carcinoma cells to TRAIL by inducing the expression of death receptors through inhibition of STAT3 activation.
    Carlisi D; D'Anneo A; Angileri L; Lauricella M; Emanuele S; Santulli A; Vento R; Tesoriere G
    J Cell Physiol; 2011 Jun; 226(6):1632-41. PubMed ID: 21413021
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Involvement of interferon regulatory factor 1 and S100C/A11 in growth inhibition by transforming growth factor beta 1 in human hepatocellular carcinoma cells.
    Miyazaki M; Sakaguchi M; Akiyama I; Sakaguchi Y; Nagamori S; Huh NH
    Cancer Res; 2004 Jun; 64(12):4155-61. PubMed ID: 15205326
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tumor-suppressor effect of interferon regulatory factor-1 in human hepatocellular carcinoma.
    Moriyama Y; Nishiguchi S; Tamori A; Koh N; Yano Y; Kubo S; Hirohashi K; Otani S
    Clin Cancer Res; 2001 May; 7(5):1293-8. PubMed ID: 11350897
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MicroRNA-138 enhances TRAIL-induced apoptosis through interferon-stimulated gene 15 downregulation in hepatocellular carcinoma cells.
    Zuo C; Sheng X; Liu Z; Ma M; Xiong S; Deng H; Li S; Yang D; Wang X; Xiao H; Quan H; Xia M
    Tumour Biol; 2017 Jun; 39(6):1010428317710410. PubMed ID: 28639887
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatitis B virus X induces cell proliferation in the hepatocarcinogenesis via up-regulation of cytoplasmic p21 expression.
    Yano M; Ohkoshi S; Aoki YH; Takahashi H; Kurita S; Yamazaki K; Suzuki K; Yamagiwa S; Sanpei A; Fujimaki S; Wakai T; Kudo SE; Matsuda Y; Aoyagi Y
    Liver Int; 2013 Sep; 33(8):1218-29. PubMed ID: 23590292
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reversibility of hAT-MSCs phenotypic and metabolic changes after exposure to and withdrawal from HCC-conditioned medium through regulation of the ROS/MAPK/HIF-1α signaling pathway.
    Wang C; Hu J; Chen Z; Wang Y; Lu S; Zhang Y; Li Y; Xiang Y; Ji Y; Zeng C; Ding Y; Wang W
    Stem Cell Res Ther; 2020 Nov; 11(1):506. PubMed ID: 33246501
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Induction of Huh‑7 cell apoptosis by HCV core proteins via CK1α‑p53‑Bid signaling pathway.
    Shen S; Li C; Dai M; Yan X
    Mol Med Rep; 2018 Jun; 17(6):7559-7566. PubMed ID: 29620268
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interferon-α2b gene-modified human bone marrow mesenchymal stem cells inhibit hepatocellular carcinoma by reducing the Notch1 levels.
    Su Y; Cheng R; Zhang J; Qian J; Diao C; Ran J; Zhang H; Li L
    Life Sci; 2015 Dec; 143():18-26. PubMed ID: 26518164
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PhiC31/PiggyBac modified stromal stem cells: effect of interferon γ and/or tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) on murine melanoma.
    Bahrambeigi V; Ahmadi N; Moisyadi S; Urschitz J; Salehi R; Haghjooy Javanmard S
    Mol Cancer; 2014 Nov; 13():255. PubMed ID: 25428727
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Type III Interferon Induces Distinct SOCS1 Expression Pattern that Contributes to Delayed but Prolonged Activation of Jak/STAT Signaling Pathway: Implications for Treatment Non-Response in HCV Patients.
    Liu B; Chen S; Guan Y; Chen L
    PLoS One; 2015; 10(7):e0133800. PubMed ID: 26193702
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rapamycin regulates the proliferation of Huh7, a hepatocellular carcinoma cell line, by up-regulating p53 expression.
    Kwon S; Jeon JS; Ahn C; Sung JS; Choi I
    Biochem Biophys Res Commun; 2016 Oct; 479(1):74-9. PubMed ID: 27616194
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Resveratrol Promoted Interferon-α-Induced Growth Inhibition and Apoptosis of SMMC7721 Cells by Activating the SIRT/STAT1.
    Yang Z; Meng Q; Zhao Y; Han R; Huang S; Li M; Wu X; Cai W; Wang H
    J Interferon Cytokine Res; 2018 Jun; 38(6):261-271. PubMed ID: 29762078
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interferon-alpha inhibits adipogenesis via regulation of JAK/STAT1 signaling.
    Lee K; Um SH; Rhee DK; Pyo S
    Biochim Biophys Acta; 2016 Nov; 1860(11 Pt A):2416-2427. PubMed ID: 27424923
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dovitinib sensitizes hepatocellular carcinoma cells to TRAIL and tigatuzumab, a novel anti-DR5 antibody, through SHP-1-dependent inhibition of STAT3.
    Chen KF; Chen HL; Liu CY; Tai WT; Ichikawa K; Chen PJ; Cheng AL
    Biochem Pharmacol; 2012 Mar; 83(6):769-77. PubMed ID: 22230479
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Endogenous IFN-β maintains M1 polarization status and inhibits proliferation and invasion of hepatocellular carcinoma cells].
    Xie C; Guo B; Liu C; Lin Y; Wu B; Wang Q; Li Z; Tu Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jul; 32(7):865-9. PubMed ID: 27363262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.